NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Pomerantz LLP
is investigating claims on behalf of investors of Fresenius Medical
Care AG & Co. KGAA ("Fresenius" or the "Company") (NYSE:
FMS). Such investors are advised to contact
Robert S. Willoughby at
rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
The investigation concerns whether Fresenius and certain of its
officers and/or directors have engaged in securities fraud or other
unlawful business practices.
[Click here to join a class action]
On January 7, 2017, Fresenius
reported that its U.S. unit had received subpoenas from federal
prosecutors seeking information on the Company's ties with the
American Kidney Fund, a charity that helps patients pay for kidney
dialysis.
On this news, Fresenius stock has fallen as much as $3.09, or 7.26%, to $39.46 on January 9,
2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los
Angeles, is acknowledged as one of the premier firms in the
areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the
Pomerantz Firm pioneered the field of securities class actions.
Today, more than 80 years later, the Pomerantz Firm continues in
the tradition he established, fighting for the rights of the
victims of securities fraud, breaches of fiduciary duty, and
corporate misconduct. The Firm has recovered numerous
multimillion-dollar damages awards on behalf of class members. See
www.pomerantzlaw.com
CONTACT:
Robert S.
Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-fresenius-medical-care-ag--co-kgaa---fms-300387869.html
SOURCE Pomerantz LLP